Cetuximab-induced nuclear localization of EGFR has been reported [20] and poor response to Cetuximab was observed in lung cancer and other solid tumors correlating with EGFR nuclear localization [35, 37, 38] thus making nuclear EGFR an important molecular target in cancer [39]. Here, EGFR is linked to lung cancer.